Jim Frates

Director of Finance/CFO at AMYLYX PHARMACEUTICALS, INC.

Net worth: 5 M $ as of 2026-06-29

58 year

76 connections

Consumer Services

Commercial Services

Health Technology

Profile

Mr. James M.
Frates is a Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at St. Francis House.
Mr. Frates was previously employed as an Independent Director by SAGE Therapeutics, Inc., a National Director by The Association of Bioscience Financial Officers, a Chief Financial Officer & Senior Vice President by Alkermes Plc, a Vice President-Investment Banking by Robertson Stephens & Co., a Treasurer & Trustee by Roxbury Latin School, and a Treasurer & Trustee by St. Paul's School.
He also served on the board at GPC Biotech AG.
He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AMYLYX PHARMACEUTICALS, INC. 0.24%	2026-04-09	261,628 ( 0.24% )	5 M $	2026-06-29

Jim Frates active positions

Companies	Position	Start
AMYLYX PHARMACEUTICALS, INC.	Director of Finance/CFO	2020-12-31
St. Francis House St. Francis House Personnel ServicesCommercial Services Provides rehabilitation services	Director/Board Member	-

All active positions of Jim Frates

Former positions of Jim Frates

Companies	Position	End
SAGE THERAPEUTICS, INC.	Director/Board Member	2025-07-30
ALKERMES PLC	Director of Finance/CFO	2021-01-10
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Director/Board Member	2009-05-31
The Association of Bioscience Financial Officers The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers	Director/Board Member	2008-12-31
Robertson Stephens & Co. Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	1998-05-31

See the detail of Jim Frates's experience

Training of Jim Frates

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jim Frates's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Commercial Services
Robertson Stephens & Co. Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services	Finance
The Association of Bioscience Financial Officers The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers	Commercial Services
St. Francis House St. Francis House Personnel ServicesCommercial Services Provides rehabilitation services	Commercial Services
St. Paul's School St. Paul's School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alkermes Plc Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer	Health Technology
SAGE Therapeutics, Inc. SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roxbury Latin School Roxbury Latin School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases	Health Technology